May 1 (UPI) --Pharmaceutical giant Johnson & Johnson on Wednesday said it is taking steps to resolve a multibillion dollar, cancer-related lawsuit with thousands of individuals over claims that ...
A subsidiary of Johnson & Johnson is now proposing to pay approximately $6.48 billion over 25 years as part of a settlement in ...
J&J will buy Momenta Pharmaceuticals for roughly $6.5 billion in cash, paving the way for its Janssen unit to expand its efforts into autoimmune disease treatments. J&J will pay $52.50 for each ...
Johnson and Johnson reiterated in its statement on Wednesday, May 1, that “none of the talc-related claims against it have ...
Johnson & Johnson is proposing a $6.5 billion settlement to resolve thousands of lawsuits claiming its talc products caused ovarian cancer. J&J aims to settle the legal claims through a third ...
Benzinga - by Vandana Singh, Benzinga Editor. Wednesday, Johnson & Johnson (NYSE:JNJ) announced its intention to proceed with a $ ...
Johnson & Johnson Wants To Deal With Talc Lawsuit Overhang, Proposes $6.5B Settlement Package Mi Aktien New York: Anleger etwas erleichtert nach US-Zinsentscheid ...
NEW BRUNSWICK (dpa-AFX) - Johnson & Johnson (JNJ) has entered into a definitive agreement to acquire Ambrx Biopharma, Inc., or Ambrx (AMAM), in an all-cash merger deal for a total equity value of ...
The Government landlord is in the spotlight. Photo / Nate McKinnon On the spectrum of business models, selling something ...
Lana Vierra misses the swing set at her Lahaina home, which was reduced to ashes in the wildfires that swept through her ...